Preclinical inflammatory disease biotech Ilias Biologics has grabbed a $20.6 million funding round as it eyes a 2021 human test of its leading candidate ILB-202. The biotech’s focus is on its ...
Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, EVerGel, in 2026, and will enhance its exosome biomanufacturing platform to advance ...
IFLScience on MSN
Exosomes: Are They Really The Cure-All Some Claim Them To Be?
If we were to zoom right into some biological tissue, be it plant or animal, then we might just see some cells that look as ...
DUBLIN--(BUSINESS WIRE)--The "Global Exosome Market: Size, Forecast, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com's offering. Exosomes are extracellular vesicles (EVs) ...
DUBLIN--(BUSINESS WIRE)--The "Exosome Diagnostics, Therapeutics and Research Tools: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for exosome ...
Exosomes -- the latest trend in high-end skin-care products -- are believed to signal cells to regenerate tissue and even attack cancer mutations. Photo by Florian Sommet/Trunk Archive. Model: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback